BAX and cervical cancer: The results indicate that GRg5, in combination with PTX, augments Bax and cleaved caspase-9 and simultaneously diminishes Bcl-2, which confirms the efficacy of GRg5 aided PTX to control PTX resistant cervical cancer cells through a mitochondrial-mediated intrinsic apoptotic pathway.